APA (7th ed.) Citation

KG, N., KR, A., S, B., TW, C., K, H., WS, L., . . . Read, R. C. (2011). Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: A randomised, multicentre, age-stratified, head-to-head trial. Lancet Infectious Diseases, 11(2), 91. https://doi.org/10.1016/s1473-3099(10)70296-6

Chicago Style (17th ed.) Citation

KG, Nicholson, et al. "Immunogenicity and Safety of a Two-dose Schedule of Whole-virion and AS03A-adjuvanted 2009 Influenza A (H1N1) Vaccines: A Randomised, Multicentre, Age-stratified, Head-to-head Trial." Lancet Infectious Diseases 11, no. 2 (2011): 91. https://doi.org/10.1016/s1473-3099(10)70296-6.

MLA (9th ed.) Citation

KG, Nicholson, et al. "Immunogenicity and Safety of a Two-dose Schedule of Whole-virion and AS03A-adjuvanted 2009 Influenza A (H1N1) Vaccines: A Randomised, Multicentre, Age-stratified, Head-to-head Trial." Lancet Infectious Diseases, vol. 11, no. 2, 2011, p. 91, https://doi.org/10.1016/s1473-3099(10)70296-6.